Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
UPDATE: Canaccord Genuity Starts Aldeyra Therapeutics (ALDX) at Buy
-
Canaccord Genuity Reiterates Hold Following AeroVironment's (AVAV) 4Q15 Results
-
ConforMIS (CFMS) Prices 9M Common Stock IPO at $15/Share
-
Egalet to Present at Upcoming Conferences This Summer
-
EMED Mining Public Limited: Quarterly Financial Statements
-
ConforMIS Announces Pricing of Its Initial Public Offering
-
ConforMIS Announces Pricing of Its Initial Public Offering
-
Unique Resources Corp. Announces Closing of its Private Placement and Reverse Takeover and Name Change to Bee Vectoring Technologies International Inc.
-
Zynerba Files Registration Statement for Proposed Initial Public Offering of Common Stock
-
Zynerba Pharmaceuticals (ZYNE) Files $57.5M Common Stock IPO
-
EMED Mining Public Limited: Posting of Annual Report
-
Vernalis plc - Appointment of Non-Executive Director
-
UPDATE: Canaccord Genuity Starts Shopify (SHOP) at Hold
-
UPDATE: Canaccord Genuity Starts Bill Barrett (BBG) at Buy
-
UPDATE: Canaccord Genuity Starts Bonanza Creek Energy (BCEI) at Buy
-
UPDATE: Canaccord Genuity Starts PDC Energy (PDCE) at Buy
-
Goldcorp announces closing of secondary offering of shares of Tahoe Resources
-
Tahoe Resources Announces Closing Of Secondary Offering By Goldcorp Inc.
-
EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants
-
UPDATE: Cantor Fitzgerald Starts Intersect ENT (XENT) at Buy
-
EnteroMedics (ETRM) Announces Common Units Offering
-
EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
Canaccord Genuity Maintains Buy on IDEXX Labs (IDXX) Following Investor Meetings
-
Alpha Peak Announces Completion of Qualifying Transaction
-
Seres Therapeutics (MCRB) IPO Opens Up 58%
-
Canaccord Genuity Maintains a Hold Rating on Nike (NKE) Following 15c EPS Beat
-
Seres Therapeutics (MCRB) IPO Prices at $18, Above Expected Range
-
Seres Therapeutics, Inc. Announces Pricing of Initial Public Offering
-
Cree (CREE) Announces Restructuring of LED; Canaccord Genuity Cuts Price Target to $28
-
Canaccord Genuity Reiterates Buy on Pandora (P) Following Investor Meetings
-
Canaccord Genuity Says Agreement with MSO Should Solidify Sequential Brands (SQBG) Position; Reiterates Buy
-
Canaccord Genuity Upgrades Gran Tierra Energy (GTE) to Buy
-
Canaccord Genuity Cuts Price Target on BlackBerry (BBRY) Following 1Q16 Results
-
Jim Rutherford Joins the Board of Dalradian Resources Inc.
-
EMED Mining Public Limited Announces Revised Admission Date
-
Dalradian Announces Results of its 2015 Meeting of Shareholders
-
UPDATE: Canaccord Genuity Starts Lipocine Inc (LPCN) at Buy
-
Pre-Open Stock Movers 06/23: (GDOT) (PHMD) (FIT) (DRI) Higher; (CTP) (VICL) (MELA) Lower (more...)
-
Canaccord Genuity Sees Ambarella (AMBA) Pullback as Buying Opportunity
-
EMED Mining Public Limited: Result of Rump Placing
-
Orsu Metals Corporation: 2015 Annual Shareholders' Meeting
-
Canaccord Genuity Raises Price Target on Exact Sciences (EXAS) Ahead of Analyst Day
-
Canaccord Genuity Upgrades Nova Measuring Instruments (NVMI) to Buy
-
EMED Mining Public Limited Announces Result of Open Offer
-
Notable 52-Week Highs and Lows 6/19: (CAG) (SGYP) (RHT) High; (HWAY) (PVA) (PVCT) Low
-
UPDATE: Canaccord Genuity Upgrades Aerie Pharma (AERI) to Buy
-
Veresen Announces Common Share Dividend for June 2015
-
Pre-Open Stock Movers 06/19 (AMCN) (AERI) (CAG) Higher; (SARA) (HWAY) (TKMR) Lower (more...)
-
Notable 52-Week Highs and Lows 6/18: (SGYP) (BMRN) (RDUS) High; (HERO) (AAVL) Low
-
Canaccord Genuity Raises Price Target on BioMarin Pharma (BMRN) Following BMN-111 Data


